Russia’s Gamaleya Center plans to study immunity to monkeypox in people vaccinated against smallpox, the Center’s director, Alexander Gintsburg, said on Thursday. "We have been tasked to study the current …
Clinical tests of a coronavirus vaccine based on virus-like particles are expected to begin in three weeks and the results are likely to be ready by autumn, director of the Gamaleya Center Alexander Gintsburg said. "The …
Developer of the Sputnik V vaccine and head of the Russian Gamaleya National Research Center Alexander Gintsburg told Anadolu Agency about how the COVID-19 pandemic can be ended. According to the scientist, the coronavirus pandemic may …
Trials of a Russian anti-coronavirus vaccine for children aged between 6 and 11 years will begin in 18-20 days, Alexander Gintsburg, the director of the Gamaleya Center that developed the Sputnik V vaccine, has told the Rossiya-24 TV channel. …
Those revaccinated with the Sputnik Light coronavirus vaccine have 100% protection against the Omicron strain within three months, Alexander Gintsburg, director of the Gamaleya Center, the vaccine’s developer, said. …
Some ten million teenagers should be vaccinated against the coronavirus infection in Russia within six months, Alexander Gintsburg, director of the Gamaleya Center, the Sputnik V vaccine developer, said. "Based on scientific data …
\Experts from the World Health Organization (WHO) are expected to visit Russia for a verification inspection of the Sputnik V coronavirus vaccine in the coming month, Alexander Gintsburg, director of the Gamaleya Center, the vaccine’s …
The coronavirus pandemic will continue until most people develop immunity, Director of Russia’s Gamaleya Scientific Research Institute of Epidemiology and Microbiology Alexander Gintsburg told the Rossiya-24 TV channel. "I do …
The Russian Sputnik V COVID-19 vaccine’s efficacy against the Omicron variant stands at about 75%, Director of the Gamaleya Research Institute of Epidemiology and Microbiology Alexander Gintsburg said on Tuesday. "In total, …
The voluntary vaccination of children aged 12-17 with the Sputnik M vaccine may start next week, according to the Twitter account of the Russian coronavirus vaccine Sputnik V citing Director of the Gamaleya National Research Center for …
The SARS-CoV-2 Omicron variant is no more dangerous that the Delta strain but it spreads faster in the population, director of the Gamaleya Center Alexander Gintsburg said. "To date, according to the preliminary data we have, …
Alexander Gintsburg, director of the Russian Health Ministry's Gamaleya Epidemiology and Microbiology Research Institute and a member of the Russian Academy of Sciences, said he doubts that the Omicron variant of the novel coronavirus …
Initial data on the effectiveness of the Sputnik V vaccine against the Omicron strain may be obtained as early as next week, Director of the Gamaleya National Research Center for Epidemiology and Microbiology Alexander Gintsburg told the …
It is possible to create a vaccine adapted to a new coronavirus variant without a sample of a new strain, including Omicron, if a nucleotide sequence of the virus is known, Director of the Gamaleya National Research Center for Epidemiology and …
The Gamaleya Center has filed with the Russian Ministry of Health the documents for conducting clinical research into a coronavirus vaccine for children aged 6 to 11, the center’s director, Alexander Gintsburg, told journalists on …
Teenagers who will get the Sputnik M coronavirus vaccine will develop the same immunity as vaccinated adults, Director General of Russia’s Gamaleya Research Institute of Epidemiology and Microbiology Alexander Gintsburg said. …
An intranasal vaccine against coronavirus developed by the Gamaleya National Research Center for Epidemiology and Microbiology can be used for revaccination together with Sputnik Light in the future, the Center’s Director Alexander …
Russia's Gamaleya National Research Centre of Epidemiology and Microbiology is developing a medicine containing antibodies to treat coronavirus patients, the centre's director, Alexander Gintsburg, said. "We are currently …
Gamaleya Center specialists have discovered that 300 antibodies are sufficient for protection against the coronavirus Delta strain, Center’s Director Alexander Gintsburg told the …
About 80% of citizens who say that they were vaccinated with Sputnik V, but fell ill with a new coronavirus infection in a severe form, simply bought their vaccination certificates, head of the Gamaleya Center Alexander Gintsburg said. …
